Another front-runner, Moderna, said Monday that its vaccine, which uses similar technology, was 94.5% effective and that the company also expected to apply soon for emergency authorisation. There are an estimated 17 million to 20 million health care workers in the United States, and about 1 million people living in nursing homes. Regulators at the FDA plan to take about three weeks to review Pfizer’s vaccine before an outside panel of experts meets to review the application the second week of December. If committee members reach a consensus about the effectiveness of Pfizer’s vaccine, the company could receive emergency clearance by mid-December. Because Moderna is also on the verge of submitting its vaccine for review, the outside panel could review the company’s vaccine soon after Pfizer’s.

Source: bd News24 November 20, 2020 21:45 UTC